• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of marker drugs to measure organ function: a theoretical interpretation.

作者信息

Cobby J, Makoid M C

出版信息

Eur J Clin Pharmacol. 1980 Nov;18(6):511-6. doi: 10.1007/BF00874665.

DOI:10.1007/BF00874665
PMID:7461018
Abstract

An equation is presented which describes the changes in drug clearance through an isolated organ due to alterations in the blood flow to the organ or the intrinsic clearance of the drug by the organ. In the case of hepatic clearance, example calculations of alterations in both parameters are presented from literature data for marker drugs having high and low extraction ratios. The predicted hepatic clearance of d-propranolol based on these calculations compares with observed values. For the particular example of the kidney, the blood flow and the intrinsic clearance change in proportion and, therefore, yield a simple equation relating renal clearance of any drug to endogenous creatinine clearance. This equation, though used clinically, has previously not been derived theoretically.

摘要

相似文献

1
The use of marker drugs to measure organ function: a theoretical interpretation.
Eur J Clin Pharmacol. 1980 Nov;18(6):511-6. doi: 10.1007/BF00874665.
2
Altered hepatic blood flow and drug disposition.肝脏血流和药物处置的改变。
Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005.
3
Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.通过体外测量内在清除率预测肝脏提取率。
J Pharmacol Exp Ther. 1977 Feb;200(2):420-4.
4
Drug dosage in renal disease.肾病中的药物剂量
Clin Pharmacokinet. 1976;1(2):126-34. doi: 10.2165/00003088-197601020-00004.
5
Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.慢性肾衰竭对高度经肝脏代谢药物处置的影响。
Int J Clin Pharmacol Ther. 2000 May;38(5):245-53. doi: 10.5414/cpp38245.
6
The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow.氟烷对药物处置的影响:内在药物代谢能力和肝血流量变化的作用。
Anesthesiology. 1985 Jul;63(1):70-6. doi: 10.1097/00000542-198507000-00011.
7
Consequences of renal insufficiency on the hepatic clearance of some drugs.肾功能不全对某些药物肝脏清除率的影响。
Int J Clin Pharmacol Res. 1983;3(6):459-74.
8
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.婴儿肝脏和肾脏全身清除途径的个体发生:第二部分。
Clin Pharmacokinet. 2002;41(13):1077-94. doi: 10.2165/00003088-200241130-00005.
9
Dose adjustment in patients with liver disease.肝病患者的剂量调整。
Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005.
10
Propranolol disposition in renal failure.肾衰竭时普萘洛尔的处置
Br J Clin Pharmacol. 1980 Dec;10(6):561-6. doi: 10.1111/j.1365-2125.1980.tb00511.x.

本文引用的文献

1
Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.成年男性肾小球滤过率、有效肾血浆流量和肾小管排泄能力的年龄变化。
J Clin Invest. 1950 May;29(5):496-507. doi: 10.1172/JCI102286.
2
Hepatic uptake and biliary excretion of indocyanine green in the dog.吲哚菁绿在犬体内的肝脏摄取及胆汁排泄
Proc Soc Exp Biol Med. 1958 Oct;99(1):11-4. doi: 10.3181/00379727-99-24229.
3
Drug dosage in patients with renal disease.肾病患者的药物剂量。
Clin Pharmacol Ther. 1974 Jul;16(1):274-80. doi: 10.1002/cpt1974161part2274.
4
Clearance concepts in pharmacokinetics.药代动力学中的清除概念。
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
5
Pharmacokinetic design of digoxin dosage regimens in relation to renal function.与肾功能相关的地高辛给药方案的药代动力学设计
J Clin Pharmacol. 1974 Oct;14(10):525-35. doi: 10.1002/j.1552-4604.1974.tb01367.x.
6
Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.苯巴比妥治疗后猴子体内安替比林和d-普萘洛尔清除率增加。酶诱导和肝血流量增加的相对作用。
J Clin Invest. 1974 Apr;53(4):1101-7. doi: 10.1172/JCI107647.
7
Determination of drug metabolizing enzymes in needle biopsies of human liver.人肝脏穿刺活检中药物代谢酶的测定
Eur J Clin Pharmacol. 1972 Mar;4(2):65-73. doi: 10.1007/BF00562499.
8
Pharmacokinetics of 125I-iothalamate and 131I-o-iodohippurate in man.125I-碘肽酸钠和131I-邻碘马尿酸在人体中的药代动力学。
J Clin Pharmacol. 1976 Feb-Mar;16(2-3):142-8. doi: 10.1002/j.1552-4604.1976.tb02395.x.
9
Commentary: a physiological approach to hepatic drug clearance.述评:肝脏药物清除的生理学方法
Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.
10
Prediction of drug dosage in patients with renal failure using data derived from normal subjects.
Clin Pharmacol Ther. 1975 Jul;18(1):45-52. doi: 10.1002/cpt197518145.